Albumin–globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients

Albumin–globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients

<p>Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, yet the heterogeneity of treatment responses underscores the need for reliable prognostic biomarkers. The albumin-to-globulin ratio (AGR), an indicator of systemic inflammation and nutritional status, has emerged as a pote...

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Kaixiang He (13263834) (author)
Diğer Yazarlar:	Fujiang Xu (5506013) (author), Li Xiang (586649) (author), Yuhao Luo (2826512) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Medicine Cell Biology Pharmacology Immunology Cancer Science Policy Mathematical Sciences not elsewhere classified Immune checkpoint inhibitors renal cell carcinoma cancer prognosis therapeutic response
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Table 2_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
Yazar:: Rui Wang (52434)
Baskı/Yayın Bilgisi: (2025)

Table 3_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
Yazar:: Rui Wang (52434)
Baskı/Yayın Bilgisi: (2025)

Table 1_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.xlsx
Yazar:: Rui Wang (52434)
Baskı/Yayın Bilgisi: (2025)

Comparative transcriptome atlas as an assistive modality for complex classification of rare kidney cancers
Yazar:: Hasashi Hasumi (21471185)
Baskı/Yayın Bilgisi: (2025)

Table 1_Mechanistic study of TFE3 breakage in TFE3-rearranged renal cell carcinoma: the perspective of non-canonical DNA structures and their stability.docx
Yazar:: Xiaopo Zhang (402895)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables TS1-23 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
Yazar:: Xiaofan Lu (15049989)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Yazar:: Hailong Pang (12841991)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 2_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Yazar:: Hailong Pang (12841991)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 1_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Yazar:: Hailong Pang (12841991)
Baskı/Yayın Bilgisi: (2025)

Additional file 14 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
Yazar:: Xu Han (141301)
Baskı/Yayın Bilgisi: (2025)

Additional file 13 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
Yazar:: Xu Han (141301)
Baskı/Yayın Bilgisi: (2025)

Additional file 12 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
Yazar:: Xu Han (141301)
Baskı/Yayın Bilgisi: (2025)

Additional file 11 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
Yazar:: Xu Han (141301)
Baskı/Yayın Bilgisi: (2025)

Table 1_Machine learning-based differentiation of lung squamous cell carcinoma and adenocarcinoma using clinical-semantic and radiomic features.docx
Yazar:: Yanju Li (9697993)
Baskı/Yayın Bilgisi: (2025)

Table 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.docx
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Table 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Table 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 9_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 10_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 11_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 7_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 8_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 5_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 6_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 4_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Table 1_The CD300c antibody CL7 suppresses tumor growth by regulating the tumor microenvironment in non-small cell lung carcinoma.docx
Yazar:: Soyoung Kim (117362)
Baskı/Yayın Bilgisi: (2025)

Image 3_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.jpeg
Yazar:: Xi Chen (35903)
Baskı/Yayın Bilgisi: (2025)

Table 2_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.docx
Yazar:: Xi Chen (35903)
Baskı/Yayın Bilgisi: (2025)

Table 1_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.xlsx
Yazar:: Xi Chen (35903)
Baskı/Yayın Bilgisi: (2025)

Image 1_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.jpeg
Yazar:: Xi Chen (35903)
Baskı/Yayın Bilgisi: (2025)

Image 2_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.png
Yazar:: Xi Chen (35903)
Baskı/Yayın Bilgisi: (2025)

Image 4_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.png
Yazar:: Xi Chen (35903)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.docx
Yazar:: Liying Ren (11143129)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables S1-S10 from <i>ACTA2</i> Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer
Yazar:: Sunho Park (15053897)
Baskı/Yayın Bilgisi: (2025)

Table 1_Preoperative TACE with PD-1 inhibitors and TKIs in beyond “up-to-seven” hepatocellular carcinoma: a propensity score matched analysis.docx
Yazar:: Deyuan Zhong (13217892)
Baskı/Yayın Bilgisi: (2025)

Table 1_Low-dose statins combined with repetitive transcranial magnetic stimulation reduce post-stroke depression.docx
Yazar:: Chaohua Cui (1793155)
Baskı/Yayın Bilgisi: (2025)

Table 1_Association between the age-to-serum albumin ratio and all-cause mortality in patients with acute myocardial infarction: a retrospective cohort study.pdf
Yazar:: Xue-Cheng Song (22679321)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_saag63fq2541rd1u3uncmps9uc